Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Apr 2, 2013

Top 22 R&D Spenders among Tool and Technologies Companies

Find out how much money goes into developing the instruments you use for research.

Top 22 R&D Spenders among Tool and Technologies Companies

These tool and tech providers are investing the most in R&D among those in the biotechnology arena. [Natalia Merzlyakova - Fotolia.com]

  • #11. Danaher Life Sciences & Diagnostics4

    2012 R&D spending: $418 million

    2011 R&D spending: $341 million

    % Change: 22.6%

    2012 percentage of sales: 6.5%

    2011 percentage of sales: 7.3%

  • #10. Bruker

    2012 R&D spending: $195.3 million

    2011 R&D spending: $177.2 million

    % Change: 10.2%

    2012 percentage of revenues: 10.9%

    2011 percentage of revenues: 10.7%

  • #9. Merck Millipore5

    2012 R&D spending: $212.890 million (€166.1 million)6

    2011 R&D spending: $170.978 million (€133.4 million)6,7

    % Change: 24.5%

    2012 percentage of sales: 6.4%

    2011 percentage of sales: 5.6%

  • #8. Bio-Rad Laboratories

    2012 R&D spending: $214.040 million

    2011 R&D spending: $186.439 million

    % Change: 14.8%

    2012 percentage of net sales: 10.3%

    2011 percentage of net sales: 9.0%

  • #7. Illumina

    2012 R&D spending: $231.025 million

    2011 R&D spending: $196.913 million

    % Change: 17.3%

    2012 percentage of revenues: 20.1%

    2011 percentage of revenues: 18.7%

  • #6. Thermo Fisher Scientific

    2012 R&D spending: $376.4 million

    2011 R&D spending: $340.2 million

    % Change: 10.6%

    2012 percentage of revenues: 3.0%

    2011 percentage of revenues: 2.9%

  • #5. Life Technologies

    2012 R&D spending: $341.892 million

    2011 R&D spending: $377.924 million

    % Change: -9.5%

    2012 percentage of revenues: 9.0%

    2011 percentage of revenues: 10.0%

  • #4. Becton Dickinson (BD)

    2012 R&D spending: $471.755 million8

    2011 R&D spending: $469.517 million8

    % Change: 0.5%

    2012 percentage of revenues: 6.1%

    2011 percentage of revenues: 6.2%

  • #3. Agilent Technologies

    2012 R&D spending: $668 million9

    2011 R&D spending: $649 million9

    % Change: 2.9%

    2012 percentage of net revenues: 9.7%

    2011 percentage of net revenues: 9.5%

  • #2. GE Healthcare10

    2012 R&D spending: Approx. $1 billion11

    2011 R&D spending: Approx. $1 billion11

    % Change: No change

    2012 percentage of revenues: about 5.5%

    2011 percentage of revenues: about 5.5%

  • #1. Roche - Diagnostics Division12

    2012 R&D spending: $1.078 billion (CHF 1.023 billion)13

    2011 R&D spending: $978.914 million (CHF 929 million)13

    % Change: 10.1%

    2012 percentage of sales: 10.0%

    2011 percentage of sales: 9.5%



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »